Written from the source article · ◎ = company's stated target · Not investment advice
On 22 July 2026 Science Corporation announced the European commercial launch of PRIMA, stating it is the first and only treatment shown in clinical trials to restore functional central vision to patients with geographic
Create a free account to read the full summary, key facts and the original source for every signal.
Create a free accountEvery Monday: up to 5 major breakthroughs and launches, explained in plain English. Free. No account needed.
One email a week. Unsubscribe anytime.